257 related articles for article (PubMed ID: 16680151)
1. Identification of a tumour suppressor network opposing nuclear Akt function.
Trotman LC; Alimonti A; Scaglioni PP; Koutcher JA; Cordon-Cardo C; Pandolfi PP
Nature; 2006 May; 441(7092):523-7. PubMed ID: 16680151
[TBL] [Abstract][Full Text] [Related]
2. Proto-oncogene PML enhances antigen presentation by MHC class I molecules in human lung cancer cells.
Chang SK; Park B; Shin J; Ahn JH; Kim IH; Ahn K
Mol Cells; 2002 Aug; 14(1):130-5. PubMed ID: 12243342
[TBL] [Abstract][Full Text] [Related]
3. Reply to Agarwal: Activity against nuclear substrates is not necessarily mediated by nuclear Akt.
Leonard TA
Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6101-E6102. PubMed ID: 29907610
[No Abstract] [Full Text] [Related]
4. Ubiquitination regulates PTEN nuclear import and tumor suppression.
Trotman LC; Wang X; Alimonti A; Chen Z; Teruya-Feldstein J; Yang H; Pavletich NP; Carver BS; Cordon-Cardo C; Erdjument-Bromage H; Tempst P; Chi SG; Kim HJ; Misteli T; Jiang X; Pandolfi PP
Cell; 2007 Jan; 128(1):141-56. PubMed ID: 17218261
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells.
Naguib A; Mathew G; Reczek CR; Watrud K; Ambrico A; Herzka T; Salas IC; Lee MF; El-Amine N; Zheng W; Di Francesco ME; Marszalek JR; Pappin DJ; Chandel NS; Trotman LC
Cell Rep; 2018 Apr; 23(1):58-67. PubMed ID: 29617673
[TBL] [Abstract][Full Text] [Related]
6. PTEN plasticity: how the taming of a lethal gene can go too far.
Naguib A; Trotman LC
Trends Cell Biol; 2013 Aug; 23(8):374-9. PubMed ID: 23578748
[TBL] [Abstract][Full Text] [Related]
7. Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression.
Chen M; Pratt CP; Zeeman ME; Schultz N; Taylor BS; O'Neill A; Castillo-Martin M; Nowak DG; Naguib A; Grace DM; Murn J; Navin N; Atwal GS; Sander C; Gerald WL; Cordon-Cardo C; Newton AC; Carver BS; Trotman LC
Cancer Cell; 2011 Aug; 20(2):173-86. PubMed ID: 21840483
[TBL] [Abstract][Full Text] [Related]
8. PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.
Sahin U; de Thé H; Lallemand-Breitenbach V
Nucleus; 2014; 5(6):499-507. PubMed ID: 25482067
[TBL] [Abstract][Full Text] [Related]
9. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
[TBL] [Abstract][Full Text] [Related]
10. A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours.
Kalathur M; Toso A; Chen J; Revandkar A; Danzer-Baltzer C; Guccini I; Alajati A; Sarti M; Pinton S; Brambilla L; Di Mitri D; Carbone G; Garcia-Escudero R; Padova A; Magnoni L; Tarditi A; Maccari L; Malusa F; Kalathur RK; A Pinna L; Cozza G; Ruzzene M; Delaleu N; Catapano CV; Frew IJ; Alimonti A
Nat Commun; 2015 Jun; 6():7227. PubMed ID: 26085373
[TBL] [Abstract][Full Text] [Related]
11. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.
Nowak DG; Cho H; Herzka T; Watrud K; DeMarco DV; Wang VM; Senturk S; Fellmann C; Ding D; Beinortas T; Kleinman D; Chen M; Sordella R; Wilkinson JE; Castillo-Martin M; Cordon-Cardo C; Robinson BD; Trotman LC
Cancer Discov; 2015 Jun; 5(6):636-51. PubMed ID: 25829425
[TBL] [Abstract][Full Text] [Related]
12. Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells.
Lee SH; Johnson D; Luong R; Sun Z
J Biol Chem; 2015 Jan; 290(5):2759-68. PubMed ID: 25527506
[TBL] [Abstract][Full Text] [Related]
13. Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.
Di Mitri D; Toso A; Chen JJ; Sarti M; Pinton S; Jost TR; D'Antuono R; Montani E; Garcia-Escudero R; Guccini I; Da Silva-Alvarez S; Collado M; Eisenberger M; Zhang Z; Catapano C; Grassi F; Alimonti A
Nature; 2014 Nov; 515(7525):134-7. PubMed ID: 25156255
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.
Carver BS; Chapinski C; Wongvipat J; Hieronymus H; Chen Y; Chandarlapaty S; Arora VK; Le C; Koutcher J; Scher H; Scardino PT; Rosen N; Sawyers CL
Cancer Cell; 2011 May; 19(5):575-86. PubMed ID: 21575859
[TBL] [Abstract][Full Text] [Related]
15. History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies.
Bercier P; de Thé H
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611029
[TBL] [Abstract][Full Text] [Related]
16. Farrerol Alleviates Cerebral Ischemia-Reperfusion Injury by Promoting Neuronal Survival and Reducing Neuroinflammation.
Zhao R; Zhou X; Zhao Z; Liu W; Lv M; Zhang Z; Wang C; Li T; Yang Z; Wan Q; Xu R; Cui Y
Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38376762
[TBL] [Abstract][Full Text] [Related]
17. Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases.
Yu H; Zaveri S; Sattar Z; Schaible M; Perez Gandara B; Uddin A; McGarvey LR; Ohlmeyer M; Geraghty P
Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763671
[TBL] [Abstract][Full Text] [Related]
18. The PML hub: An emerging actor of leukemia therapies.
Rérolle D; de Thé H
J Exp Med; 2023 Aug; 220(8):. PubMed ID: 37382966
[TBL] [Abstract][Full Text] [Related]
19. Structure-Based Profiling of Potential Phytomolecules with AKT1 a Key Cancer Drug Target.
Mirza Z; Karim S
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985568
[TBL] [Abstract][Full Text] [Related]
20. Filamentous nuclear actin regulation of PML NBs during the DNA damage response is deregulated by prelamin A.
Cobb AM; De Silva SA; Hayward R; Sek K; Ulferts S; Grosse R; Shanahan CM
Cell Death Dis; 2022 Dec; 13(12):1042. PubMed ID: 36522328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
